Skip to main content
. 2019 Feb 20;36(5):1013–1021. doi: 10.1007/s10815-019-01419-8

Table 6.

Fertility preservation outcomes (survey responses per center)

How many cryopreserved patient oocytes would be sufficient for you to recommend that further treatment cycles are not necessary, if the general condition of the patient would allow her to continue cryopreservation therapy?
 1–5 6–10 11–15 More than 15 I do not have experience in the field
 18 (5.6%) 51 (15.9%) 107 (33.3%) 120 (37.4%) 25 (7.8%)
Statement: the success rate of fertility preservation is not yet good enough to make it an available option.
 Agree Neither agree nor disagree Disagree
 30 (9.3%) 46 (14.3%) 245 (76.3%)
Were there pregnancies in your center in the following situations? (multiple answers allowed)
 After cancer treatment from frozen embryos After cancer treatment from cryopreserved oocytes After fertility preservation from transplanted ovarian tissue I am not aware of any pregnancies There were no pregnancies in women with the situations stated above
 182 (56.7%) 117 (36.4%) 31 (9.7%) 57 (17.8%) 55 (17.1%)
The pregnancy rate after oocyte cryopreservation in cancer patients is not yet known because
 There are not enough patients that benefit from this procedure who have gotten as far as embryo transfer to assess the pregnancy rate The ability of cryopreserved oocytes to be fertilized is impaired There is no proper registry Other reasons
 142 (44.2%) 15 (4.7%) 136 (42.4%) 28 (8.7%)